Managing osteoporosis in ulcerative colitis: Something new?

World Journal of Gastroenterology

Volumn 20, Issue 39, 2014, Pages 14087-14098

  Piodi, Luca Petruccio ^a   Poloni, Alessandro ^b   Ulivieri, Fabio Massimo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone mineral density; Dual energy X ray absorptiometry; Fracture assessment risk tool; Fragility fracture; Hip structural analysis; Osteoporosis; Trabecular bone score; Ulcerative colitis

Indexed keywords

CALCIUM; CORTICOSTEROID; VITAMIN D; BONE DENSITY CONSERVATION AGENT;

ALCOHOL CONSUMPTION; BONE DENSITOMETRY; BONE DENSITY; BONE STRUCTURE; CALCIUM INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; FALLING; FRACTURE; FRAGILITY FRACTURE; HIP; HUMAN; OSTEOPOROSIS; PHYSICAL ACTIVITY; PREDICTION; REVIEW; SMOKING; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; COLITIS, ULCERATIVE; COMPLICATION; DIETARY SUPPLEMENT; OSTEOPOROTIC FRACTURES; PREDICTIVE VALUE; PREVENTION AND CONTROL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME;

ACCIDENTAL FALLS; ADRENAL CORTEX HORMONES; BONE DENSITY CONSERVATION AGENTS; COLITIS, ULCERATIVE; DIETARY SUPPLEMENTS; HUMANS; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84910128371     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i39.14087     Document Type: Review

References (94)

1. Ford AC, Moayyedi P, Hanauer SB. Ulcerative colitis. BMJ 2013; 346: f432 [PMID: 23386404 DOI: 10.1136/bmj.f432]
2. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Peña AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 Suppl A: 5A-36A [PMID: 16151544]
3. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013; 24: 23-57 [PMID: 23079689 DOI: 10.1007/s00198-012-2074-y]
4. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785-795 [PMID: 11176917 DOI: 10.1001/jama.285.6.785]
5. Cooper C . The crippling consequences of fractures and their impact on quality of life. Am J Med 1997; 103: 12S-17S; discussion 17S-19S [PMID: 9302893 DOI: 10.1016/S0002-9343(97)90022-X]
6. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporos Int 2000; 11: 556-561 [PMID: 11069188 DOI: 10.1007/s001980070075]
7. Gallagher JC, Genant HK, Crans GG, Vargas SJ, Krege JH. Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. J Clin Endocrinol Metab 2005; 90: 1583-1587 [PMID: 15613428 DOI: 10.1210/jc.2004-0826]
8. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E. Risk of new vertebral fracture in the year following a fracture. JAMA 2001; 285: 320-323 [PMID: 11176842 DOI: 10.1001/jama.285.3.320]
9. Cameron JR, Sorenson J. Measurement of bone mineral in vivo: an improved method. Science 1963; 142: 230-232 [PMID: 14057368 DOI: 10.1126/science.142.3589.230]
10. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994; 843: 1-129 [PMID: 7941614]
11. The International Society for Clinical Densitometry. Official ISCD Positions-Adult [Internet]. Available from: URL: http://www.iscd.org/official-positions/5th-iscd-position-develop-ment-conference-adult/
12. Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY. Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporos Int 2010; 21: 1657-1680 [PMID: 20480148 DOI: 10.1007/s00198-010-1223-4]
13. Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, Minisola S, Rossini M. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 2009; 20: 239-244 [PMID: 18551242 DOI: 10.1007/s00198-008-0650-y]
14. Baio G, Barbagallo M, D'Avola G, Di Luccio A, Di Tanna GL, Falaschi P, Iolascon G, Malavolta N, Robbiati F, Ulivieri FM. Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis. Expert Opin Pharmacother 2011; 12: 257-268 [PMID: 21226636 DOI: 10.1517/14656566.2011.537259]
15. Goodhand JR, Kamperidis N, Nguyen H, Wahed M, Rampton DS. Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis. Aliment Pharmacol Ther 2011; 33: 551-558 [PMID: 21198706 DOI: 10.1111/j.1365-2036.2010.04554.x]
16. Targownik LE, Bernstein CN, Leslie WD. Inflammatory bowel disease and the risk of osteoporosis and fracture. Maturitas 2013; 76: 315-319 [PMID: 24139749 DOI: 10.1016/j.maturitas.2013.09.009]
17. Khan N, Abbas AM, Almukhtar RM, Khan A. Prevalence and predictors of low bone mineral density in males with ulcerative colitis. J Clin Endocrinol Metab 2013; 98: 2368-2375 [PMID: 23596137 DOI: 10.1210/jc.2013-1332]
18. Ulivieri FM, Piodi LP, Taioli E, Lisciandrano D, Ranzi T, Vezzoli M, Cermesoni L, Bianchi P. Bone mineral density and body composition in ulcerative colitis: a six-year follow-up. Osteoporos Int 2001; 12: 343-348 [PMID: 11444080 DOI: 10.1007/s001980170100]
19. Targownik LE, Bernstein CN, Leslie WD. Risk factors and management of osteoporosis in inflammatory bowel disease. Curr Opin Gastroenterol 2014; 30: 168-174 [PMID: 24419292 DOI: 10.1097/MOG.0000000000000037]
20. Ghishan FK, Kiela PR. Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 2011; 300: G191-G201 [PMID: 21088237 DOI: 10.1152/ajpgi.00496.2010]
21. van Staa TP. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 2006; 79: 129-137 [PMID: 16969593 DOI: 10.1007/s00223-006-0019-1]
22. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002; 13: 777-787 [PMID: 12378366 DOI: 10.1007/s001980200108]
23. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003; 124: 795-841 [PMID: 12612917 DOI: 10.1053/gast.2003.50106]
24. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105: 501-523; quiz 524 [PMID: 20068560 DOI: 10.1038/ajg.2009.727]
25. Lewis N, Scott B. British Society of Gastroenterology - Guidelines for Osteoporosis in Inflammatory Bowel Disease and Coeliac Disease [Internet]. 2007 [cited 2014 Feb 7]. 1-16. Available from: URL: http://www.bsg.org.uk/clinical-guidelines/ibd/guidelines-for-osteoporosis-in-inflammatory-bowel-disease-and-coeliac-disease.html
26. International Society for Clinical Densitometry (ISCD). Official ISCD Positions-Adult [Internet]. 2013 [cited 2014 Mar 8]. Available from: URL: http://www.iscd.org/official-positions/2013-iscd-official-positions-adult/
27. National Osteoporosis Foundation (NOF). 2013 Clinician's Guide to the Prevention and Treatment of Osteoporosis [Internet]. 2013 [cited 2014 Feb 21]; 1-53. Available from: URL: http://nof.org/files/nof/public/content/resource/913/files/870.pdf
28. United States Food and Drug Administration. Osteoporosis [Internet]. [cited 2014 Mar 8]. Available from: URL: http://www.fda.gov/downloads/ForConsumers/ByAudience/ForWomen/FreePublications/UCM364690.pdf
29. Svedbom A, Hernlund E, Iverga˚rd M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 2013; 8: 137 [PMID: 24113838 DOI: 10.1007/s11657-013-0137-0]
30. National Institute of Health. NIH Osteoporosis and Related Bone Diseases National Resource Center [Internet]. [cited 2014 Mar 8]. Available from: URL: http://www.niams.nih.gov/Health-Info/Bone/Osteoporosis/
31. U.S. Preventive Services Task Force. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med 2011; 154: 356-364 [PMID: 21242341 DOI: 10.7326/0003-4819-154-5-201103010-00307]
32. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield U. FRAX TOOL [Internet]. [cited 2014 Mar 7]. Available from: URL: http://www.shef.ac.uk/FRAX/
33. Targownik LE, Bernstein CN, Nugent Z, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD. Inflammatory bowel disease and the risk of fracture after controlling for FRAX. J Bone Miner Res 2013; 28: 1007-1013 [PMID: 23239264 DOI: 10.1002/jbmr.1848]
34. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. Case finding for the management of osteoporosis with FRAX - assessment and intervention thresholds for the UK. Osteoporos Int 2008; 19: 1395-1408 [PMID: 18751937 DOI: 10.1007/s00198-008-0712-1]
35. Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 2013; 75: 392-396 [PMID: 23810490 DOI: 10.1016/j.maturitas.2013.05.013]
36. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005; 20: 1185-1194 [PMID: 15940371 DOI: 10.1359/JBMR.050304]
37. Hordon LD, Raisi M, Aaron JE, Paxton SK, Beneton M, Kanis JA. Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: I. Two-dimensional histology. Bone 2000; 27: 271-276 [PMID: 10913921]
38. Link TM, Majumdar S. Current diagnostic techniques in the evaluation of bone architecture. Curr Osteoporos Rep 2004; 2: 47-52 [PMID: 16036082]
39. Genant HK, Engelke K, Prevrhal S. Advanced CT bone imaging in osteoporosis. Rheumatology (Oxford) 2008; 47 Suppl 4: iv9-i16 [PMID: 18556648 DOI: 10.1093/rheumatology/ken180]
40. Bredella MA, Misra M, Miller KK, Madisch I, Sarwar A, Cheung A, Klibanski A, Gupta R. Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology 2008; 249: 938-946 [PMID: 19011190 DOI: 10.1148/radiol.2492080173]
41. Cheung AM, Adachi JD, Hanley DA, Kendler DL, Davison KS, Josse R, Brown JP, Ste-Marie LG, Kremer R, Erlandson MC, Dian L, Burghardt AJ, Boyd SK. High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr Osteoporos Rep 2013; 11: 136-146 [PMID: 23525967 DOI: 10.1007/s11914-013-0140-9]
42. Krug R, Carballido-Gamio J, Banerjee S, Burghardt AJ, Link TM, Majumdar S. In vivo ultra-high-field magnetic resonance imaging of trabecular bone microarchitecture at 7 T. J Magn Reson Imaging 2008; 27: 854-859 [PMID: 18383263 DOI: 10.1002/jmri.21325]
43. Caligiuri P, Giger ML, Favus MJ, Jia H, Doi K, Dixon LB. Computerized radiographic analysis of osteoporosis: preliminary evaluation. Radiology 1993; 186: 471-474 [PMID: 8421753 DOI: 10.1148/radiology.186.2.8421753]
44. Samarabandu J, Acharya R, Hausmann E, Allen K. Analysis of bone X-rays using morphological fractals. IEEE Trans Med Imaging 1993; 12: 466-470 [PMID: 18218438 DOI: 10.1109/42.241873]
45. Prouteau S, Ducher G, Nanyan P, Lemineur G, Benhamou L, Courteix D. Fractal analysis of bone texture: a screening tool for stress fracture risk? Eur J Clin Invest 2004; 34: 137-142 [PMID: 14764077]
46. Gregory JS, Stewart A, Undrill PE, Reid DM, Aspden RM. Identification of hip fracture patients from radiographs using Fourier analysis of the trabecular structure: a cross-sectional study. BMC Med Imaging 2004; 4: 4 [PMID: 15469614 DOI: 10.1186/1471-2342-4-4]
47. Chappard D, Guggenbuhl P, Legrand E, Baslé MF, Audran M. Texture analysis of X-ray radiographs is correlated with bone histomorphometry. J Bone Miner Metab 2005; 23: 24-29 [PMID: 15616890 DOI: 10.1007/s00774-004-0536-9]
48. Vokes TJ, Giger ML, Chinander MR, Karrison TG, Favus MJ, Dixon LB. Radiographic texture analysis of densitometergenerated calcaneus images differentiates postmenopausal women with and without fractures. Osteoporos Int 2006; 17: 1472-1482 [PMID: 16838099 DOI: 10.1007/s00198-006-0089-y]
49. Bonnick SL. Bone Densitometry in Clinical Practice: Application and Interpretation. 3rd ed. 20. 978-1603274982: Humana Press, 2009
50. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8: 1137-1148 [PMID: 8237484 DOI: 10.1002/jbmr.5650080915]
51. Duboeuf F, Bauer DC, Chapurlat RD, Dinten JM, Delmas P. Assessment of vertebral fracture using densitometric morphometry. J Clin Densitom 2005; 8: 362-368 [PMID: 16055969]
52. Faulkner KG, Cummings SR, Black D, Palermo L, Glüer CC, Genant HK. Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res 1993; 8: 1211-1217 [PMID: 8256658 DOI: 10.1002/jbmr.5650081008]
53. Beck TJ, Ruff CB, Warden KE, Scott WW, Rao GU. Predicting femoral neck strength from bone mineral data. A structural approach. Invest Radiol 1990; 25: 6-18 [PMID: 2298552]
54. Nakamura T, Turner CH, Yoshikawa T, Slemenda CW, Peacock M, Burr DB, Mizuno Y, Orimo H, Ouchi Y, Johnston CC. Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res 1994; 9: 1071-1076 [PMID: 7942154 DOI: 10.1002/jbmr.5650090715]
55. Langton CM, Pisharody S, Keyak JH. Comparison of 3D finite element analysis derived stiffness and BMD to determine the failure load of the excised proximal femur. Med Eng Phys 2009; 31: 668-672 [PMID: 19230742 DOI: 10.1016/j.medengphy.2008.12.007]
56. Boehm HF, Vogel T, Panteleon A, Burklein D, Bitterling H, Reiser M. Differentiation between post-menopausal women with and without hip fractures: enhanced evaluation of clinical DXA by topological analysis of the mineral distribution in the scan images. Osteoporos Int 2007; 18: 779-787 [PMID: 17235663 DOI: 10.1007/s00198-006-0302-z]
57. Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA. Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 2011; 14: 302-312 [PMID: 21724435 DOI: 10.1016/j.jocd.2011.05.005]
58. Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 2014; 29: 518-530 [PMID: 24443324 DOI: 10.1002/jbmr.2176]
59. Winzenrieth R, Michelet F, Hans D. Three-dimensional (3D) microarchitecture correlations with 2D projection image graylevel variations assessed by trabecular bone score using highresolution computed tomographic acquisitions: effects of resolution and noise. J Clin Densitom 2013; 16: 287-296 [PMID: 22749406 DOI: 10.1016/j.jocd.2012.05.001]
60. Roux JP, Wegrzyn J, Boutroy S, Bouxsein ML, Hans D, Chapurlat R. The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study. Osteoporos Int 2013; 24: 2455-2460 [PMID: 23468074 DOI: 10.1007/s00198-013-2316-7]
61. Ulivieri FM, Silva BC, Sardanelli F, Hans D, Bilezikian JP, Caudarella R. Utility of the trabecular bone score (TBS) in secondary osteoporosis. Endocrine 2014; Epub ahead of print [PMID: 24853880]
62. Crabtree NJ, Kroger H, Martin A, Pols HA, Lorenc R, Nijs J, Stepan JJ, Falch JA, Miazgowski T, Grazio S, Raptou P, Adams J, Collings A, Khaw KT, Rushton N, Lunt M, Dixon AK, Reeve J. Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporos Int 2002; 13: 48-54 [PMID: 11883408 DOI: 10.1007/s198-002-8337-y]
63. Martin RB, Burr DB. Non-invasive measurement of long bone cross-sectional moment of inertia by photon absorptiometry. J Biomech 1984; 17: 195-201 [PMID: 6736056 DOI: 10.1016/0021-9290(84)90010-1]
64. Danielson ME, Beck TJ, Karlamangla AS, Greendale GA, Atkinson EJ, Lian Y, Khaled AS, Keaveny TM, Kopperdahl D, Ruppert K, Greenspan S, Vuga M, Cauley JA. A comparison of DXA and CT based methods for estimating the strength of the femoral neck in post-menopausal women. Osteoporos Int 2013; 24: 1379-1388 [PMID: 22810918 DOI: 10.1007/s00198-012-2066-y]
65. Ramamurthi K, Ahmad O, Engelke K, Taylor RH, Zhu K, Gustafsson S, Prince RL, Wilson KE. An in vivo comparison of hip structure analysis (HSA) with measurements obtained by QCT. Osteoporos Int 2012; 23: 543-551 [PMID: 21394495 DOI: 10.1007/s00198-011-1578-1]
66. Kaptoge S, Dalzell N, Loveridge N, Beck TJ, Khaw KT, Reeve J. Effects of gender, anthropometric variables, and aging on the evolution of hip strength in men and women aged over 65. Bone 2003; 32: 561-570 [PMID: 12753873 DOI: 10.1016/S8756-3282(03)00055-3]
67. Hamilton CJ, Jamal SA, Beck TJ, Khaled AS, Adachi JD, Brown JP, Davison KS. Evidence for impaired skeletal load adaptation among Canadian women with type 2 diabetes mellitus: insight into the BMD and bone fragility paradox. Metabolism 2013; 62: 1401-1405 [PMID: 23768546 DOI: 10.1016/j.metabol.2013.05.004]
68. Kocijan R, Muschitz C, Fratzl-Zelman N, Haschka J, Dimai HP, Trubrich A, Bittighofer C, Resch H. Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta. Skeletal Radiol 2013; 42: 187-194 [PMID: 22955449 DOI: 10.1007/s00256-012-1512-4]
69. Uusi-Rasi K, Semanick LM, Zanchetta JR, Bogado CE, Eriksen EF, Sato M, Beck TJ. Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 2005; 36: 948-958 [PMID: 15878318 DOI: 10.1016/j.bone.2005.03.003]
70. Committee to Review Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine of the USA national academies. Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press; 9780309163941, 2011. Available from: URL: http://www.nap.edu/openbook.php?record-id=13050
71. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930 [PMID: 21646368 DOI: 10.1210/jc.2011-0385]
72. Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 2011; 35: 308-316 [PMID: 21527593 DOI: 10.1177/0148607110381267]
73. Kuwabara A, Tanaka K, Tsugawa N, Nakase H, Tsuji H, Shide K, Kamao M, Chiba T, Inagaki N, Okano T, Kido S. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int 2009; 20: 935-942 [PMID: 18825300 DOI: 10.1007/s00198-008-0764-2]
74. Khan AA, Dragt BS, Porte RJ, Groothuis GM. Regulation of VDR expression in rat and human intestine and liver - consequences for CYP3A expression. Toxicol In Vitro 2010; 24: 822-829 [PMID: 20006981 DOI: 10.1016/j.tiv.2009.12.011]
75. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008; 29: 407-414 [PMID: 18727936 DOI: 10.1016/j.mam.2008.07.002]
76. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86: 888-894 [PMID: 11158062 DOI: 10.1210/jcem.86.2.7220]
77. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 827-838 [PMID: 22184690 DOI: 10.7326/0003-4819-155-12-201112200-00005]
78. Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA 2008; 105: 20834-20839 [PMID: 19095793 DOI: 10.1073/pnas.0808700106]
79. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003; 89: 922-932 [PMID: 12874827 DOI: 10.1002/jcb.10580]
80. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004; 80: 1717S-1720S [PMID: 15585793]
81. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 2386-2392 [PMID: 14500760 DOI: 10.1210/me.2003-0281]
82. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, Li YC. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294: G208-G216 [PMID: 17962355 DOI: 10.1152/ajpgi.00398.2007]
83. Melek J, Sakuraba A. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review. Clin Gastroenterol Hepatol 2014; 12: 32-44.e5 [PMID: 23981521 DOI: 10.1016/j.cgh.2013.08.024]
84. Kitazaki S, Mitsuyama K, Masuda J, Harada K, Yamasaki H, Kuwaki K, Takedatsu H, Sugiyama G, Tsuruta O, Sata M. Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis. Aliment Pharmacol Ther 2009; 29: 424-430 [PMID: 19035979 DOI: 10.1111/j.1365-2036.2008.03899.x]
85. Kriel MH, Tobias JH, Creed TJ, Lockett M, Linehan J, Bell A, Przemioslo R, Smithson JE, Brooklyn TN, Fraser WD, Probert CS. Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease. Osteoporos Int 2010; 21: 507-513 [PMID: 19484170 DOI: 10.1007/s00198-009-0960-8]
86. Pappa HM, Saslowsky TM, Filip-Dhima R, DiFabio D, Hassani Lahsinoui H, Akkad A, Grand RJ, Gordon CM. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial. Am J Gastroenterol 2011; 106: 1527-1543 [PMID: 21519359 DOI: 10.1038/ajg.2011.129]
87. Russell RG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008; 19: 733-759 [PMID: 18214569 DOI: 10.1007/s00198-007-0540-8]
88. Pazianas M, Russell RG. Potential therapeutic effects of oral bisphosphonates on the intestine. Ann N Y Acad Sci 2011; 1240: E19-E25 [PMID: 22360293 DOI: 10.1111/j.1749-6632.2011.06372.x]
89. Guenther A, Gordon S, Tiemann M, Burger R, Bakker F, Green JR, Baum W, Roelofs AJ, Rogers MJ, Gramatzki M. The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation. Int J Cancer 2010; 126: 239-246 [PMID: 19621390 DOI: 10.1002/ijc.24758]
90. Walker K, Olson MF. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. Curr Opin Genet Dev 2005; 15: 62-68 [PMID: 15661535 DOI: 10.1016/j.gde.2004.11.001]
91. Ballester I, Daddaoua A, López-Posadas R, Nieto A, Suárez MD, Zarzuelo A, Martínez-Augustin O, Sánchez de Medina F. The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats. Br J Pharmacol 2007; 151: 206-215 [PMID: 17375077 DOI: 10.1038/sj.bjp.0707227]
92. Sassa S, Okabe H, Nemoto N, Kikuchi H, Kudo H, Sakamoto S. Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis. Anticancer Res 2009; 29: 4615-4619 [PMID: 20032411]
93. Roelofs AJ, Jauhiainen M, Mönkkönen H, Rogers MJ, Mönkkönen J, Thompson K. Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. Br J Haematol 2009; 144: 245-250 [PMID: 19016713 DOI: 10.1111/j.1365-2141.2008.07435.x]
94. Benzaid I, Clézardin P. Nitrogen-containing bisphosphonates and human γδ T cells. IBMS Bonekey 2010; 7: 208-217 [DOI: 10.1138/20100450]